Package 68788-8203-5

Brand: acyclovir

Generic: acyclovir
NDC Package

Package Facts

Identity

Package NDC 68788-8203-5
Digits Only 6878882035
Product NDC 68788-8203
Description

50 TABLET in 1 BOTTLE (68788-8203-5)

Marketing

Marketing Status
Marketed Since 2022-05-26
Brand acyclovir
Generic acyclovir
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "67f406ad-9398-4613-a77a-439966f1d0ae", "openfda": {"nui": ["N0000020060", "N0000180187", "N0000180188", "N0000175468", "N0000175459"], "unii": ["X4HES1O11F"], "rxcui": ["197311"], "spl_set_id": ["b1033fda-8242-4006-b1cd-23474d70671f"], "pharm_class_epc": ["Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]"], "pharm_class_moa": ["DNA Polymerase Inhibitors [MoA]"], "manufacturer_name": ["Preferred Pharmaceuticals Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (68788-8203-1)", "package_ndc": "68788-8203-1", "marketing_start_date": "20220526"}, {"sample": false, "description": "21 TABLET in 1 BOTTLE (68788-8203-2)", "package_ndc": "68788-8203-2", "marketing_start_date": "20220526"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (68788-8203-3)", "package_ndc": "68788-8203-3", "marketing_start_date": "20220526"}, {"sample": false, "description": "40 TABLET in 1 BOTTLE (68788-8203-4)", "package_ndc": "68788-8203-4", "marketing_start_date": "20220526"}, {"sample": false, "description": "50 TABLET in 1 BOTTLE (68788-8203-5)", "package_ndc": "68788-8203-5", "marketing_start_date": "20220526"}, {"sample": false, "description": "35 TABLET in 1 BOTTLE (68788-8203-8)", "package_ndc": "68788-8203-8", "marketing_start_date": "20220526"}], "brand_name": "Acyclovir", "product_id": "68788-8203_67f406ad-9398-4613-a77a-439966f1d0ae", "dosage_form": "TABLET", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "68788-8203", "generic_name": "Acyclovir", "labeler_name": "Preferred Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Acyclovir", "active_ingredients": [{"name": "ACYCLOVIR", "strength": "400 mg/1"}], "application_number": "ANDA209366", "marketing_category": "ANDA", "marketing_start_date": "20220526", "listing_expiration_date": "20271231"}